View of Impact of HbF inducers use on anti-cardiolipin and anti-beta2-glycoprotein I antibody levels in beta-thalassemia patients: a pilot study

Return to Article Details Impact of HbF inducers use on anti-cardiolipin and anti-beta2-glycoprotein I antibody levels in beta-thalassemia patients: a pilot study Download Download PDF